Clinical Trial Update: THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on lixivaptan for treating hyponatremia in NYHA Class III/IV heart failure patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Lixivaptan (lixivaptan)

Snippet

Sponsor: CardioKine Inc. | Conditions: Hyponatremia | Phase 3 | Status: COMPLETED